Ann D. Rhoads - 25 Jun 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Reporting relationship: Director
Issuer ticker: QDEL
Reported as of: 25 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jun 2026, 17:59:27 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads

Key filing fact

Ann D. Rhoads filed Form 4 for QuidelOrtho Corp (QDEL) on 29 Jun 2026.

Key facts

This page summarizes Ann D. Rhoads's Form 4 filing for QuidelOrtho Corp (QDEL).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 17:59.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001250252 Primary reporting owner

RHOADS ANN D

Relationship: Director
Address: 9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature: /s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads
Signature date: 29 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units (Equity Grant)

Award

Transaction value
Shares: +15,532
Change %
Price: $0.000000^*
Shares after: 15,532
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,532
Exercise price
Footnotes: F1, F2

QDEL transaction Derivative

Restricted Stock Units (Converted)

Award

Transaction value
Shares: +3,698
Change %
Price: $0.000000^*
Shares after: 3,698
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,698
Exercise price
Footnotes: F1, F3, F4

QDEL transaction Derivative

Restricted Stock Units (Premium)

Award

Transaction value
Shares: +369
Change %
Price: $0.000000^*
Shares after: 369
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 369
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F2

The restricted stock units will vest on June 25, 2027.

Footnote F3

The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.

Footnote F4

924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027.